THE GROUP’S PRODUCT AMOXICILLIN SODIUMAND CLAVULANATE POTASSIUM FOR INJECTIONPASSED THE CONSISTENCY EVALUATION

The launch ceremony of the self-made dilute acid and dilute alkali project of The United Laboratories (Inner Mongolia) Co., Ltd.was grandly held

At the 2025 (42nd) National Pharmaceutical Industry Information Conference, the top 100 enterprises in China's pharmaceutical industry main business revenue for 2024 were announced,with Zhuhai United Laboratories Co., Ltd. ranking 23rd.

FDA APPROVAL OF IND FOR UBT37034 INJECTION

TUL showcased its new products at CPHI China 2025 and won two major awards

Seminar on deepening e-commerce cooperation between TUL and JD Health was successfully held at Zhuhai United Laboratories Co., Ltd.

Senior delegation from Novo Nordisk visited The United Bio-Technology (Hengqin) Co., Ltd.

TUL held its 2025 Annual General Meeting of Shareholders in Hong Kong

TUL had received an advance payment of 180 million US dollars from Novo Nordisk